Format

Send to

Choose Destination
EMBO Rep. 2017 Sep;18(9):1671. doi: 10.15252/embr.201744761.

Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition.

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center